Tiltrædelsesforelæsning ved professor Clare Hawkins – Københavns Universitet

Videresend til en ven Resize Print Bookmark and Share

Biomedicinsk Institut > Nyheder > Tiltrædelsesforelæsnin...

31. maj 2017

Tiltrædelsesforelæsning ved professor Clare Hawkins

Tiltrædelsesforelæsning

Clare Hawkins er for nyligt blevet udnævnt som professor på Biomedicinsk Institut og afholder i den forbindelse en tiltrædelsesforelæsning.

Instituttet vil gerne invitere alle til at fejre udnævnelsen med en tiltrædelsesforelæsning af professor Clare Hawkins under titlen "Inflammation, Oxidation and Atherosclerosis".

Forelæsningen finder sted den 15. september 2017 kl. 14.30 i Dam Auditoriet på Panum. Efter forelæsningen afholdes der en reception i Faculty Club.

Nedenfor kan du læse den engelske beskrivelse af Clares forskning:

Atherosclerosis is the major cause of cardiovascular disease
Cardiovascular diseases are the leading cause of death in the EU, and account for one quarter of all deaths in Denmark. The primary underlying cause of most cardiovascular disease is atherosclerosis - the abnormal build-up of cholesterol and fatty deposits within the arterial wall, which progresses over decades to form complex plaques and lesions that eventually lead to heart attacks and strokes. The incidence of atherosclerosis is increasing worldwide, owing to the epidemic of obesity, diabetes and associated metabolic disorders. Currently, the main treatment for atherosclerosis involves the use of statin drugs to lower patient cholesterol levels to slow the development of lesions. However, statins are not tolerated by all patients, and a significant cardiovascular risk remains, highlighting the need for the development of more effective therapies to treat atherosclerosis and reduce the incidence of cardiovascular disease.

Professor Clare Hawkins’ research is focused on understanding how chronic inflammation drives the development of atherosclerosis. Her primary interest concerns understanding how oxidants produced during inflammation modify the structure and function of biological molecules and cells associated with the arterial wall, as a means to develop more targeted therapies to prevent lesion formation and slow the progression of atherosclerosis. Clare relocated to Copenhagen after nearly 20 years in Sydney, Australia, at the Heart Research Institute, were she moved following the completion of her PhD in the Department of Chemistry, University of York, England in 1997. Clare is a former Australian Research Council Future Fellow and Principal Research Fellow within Sydney Medical School, University of Sydney. While in Australia, Clare held a number of other prestigious Career Fellowships and Project Grants from major Australian funding agencies, including the National Health and Medical Research Council and National Heart Foundation.